StonvexLoading…
StonvexStonvexStonvexCore line items from DHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-27 | Annual 2025 2025-12-31 | Q3 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $5.95B | $24.57B | $17.73B | $11.68B |
Operating Income | $1.34B | $4.69B | $3.19B | $2.03B |
Net Income | $1.03B | $3.61B | $2.42B | $1.51B |
EPS (Diluted) | $1.45 | $5.05 | $3.37 | $2.10 |
Total Assets | $83.54B | $83.46B | $79.90B | $81.62B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.70B | $4.62B | $1.53B | $2.96B |
Free Cash Flow OCF − CapEx | $1.08B | $5.26B | $3.51B | $2.14B |
Shares Outstanding | 707.70M | 706.90M | 706.30M | 715.90M |